CG
CLB icon

Clinton Group’s Core Laboratories CLB Stock Holding History

Clinton Group’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-31,576
Closed -$3.2M – 412
2017
Q2 		$3.2M Buy
+31,576
New +$3.4M 0.33% 104
2016
Q4 		– Sell
-44,241
Closed -$4.97M – 826
2016
Q3 		$4.97M Buy
44,241
+15,736
+55% +$1.81M 0.23% 125
2016
Q2 		$3.53M Buy
+28,505
New +$3.44M 0.15% 185
2016
Q1 		– Sell
-9,014
Closed -$980K – 881
2015
Q4 		$980K Sell
9,014
-2,071
-19% -$237K 0.08% 362
2015
Q3 		$1.11M Buy
+11,085
New +$1.21M 0.1% 276
2014
Q4 		– Sell
-4,844
Closed -$709K – 478
2014
Q3 		$709K Buy
+4,844
New +$748K 0.29% 109

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Clinton Group's CLB Position: Q3 2017 in Review

Clinton Group sold out of Core Laboratories (CLB) in Q3 2017, closing a stake of 31,576 shares — an estimated $3.2M sold.

Clinton Group first reported a position in CLB in Q3 2014 and held it in 6 quarters. The position peaked at $4.97M in Q3 2016. 345 funds tracked by Wall St. Rank hold CLB as of Q3 2017.

  • Clinton Group reported no remaining Core Laboratories position as of Q3 2017 after selling out during the quarter.
  • Clinton Group sold 31,576 Core Laboratories shares in Q3 2017, an estimated $3.2M.
  • Clinton Group first reported a position in Core Laboratories in Q3 2014 and held it in 6 quarters.
  • Clinton Group's Core Laboratories position peaked at $4.97M in Q3 2016.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2017.

Based on Clinton Group's 13F filing for Q3 2017, filed 14 Nov 2017.